Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 865
Filtrar
Más filtros

Intervalo de año de publicación
1.
Trop Anim Health Prod ; 55(3): 190, 2023 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-37140716

RESUMEN

The objective of the present study was to evaluate the effects of increasing doses of protease on broilers from 1 to 42 days of age. A total of 1290 Ross AP broilers were used, distributed among five treatments: positive control diet, negative control diet (NC), NC + 50 ppm of protease, NC + 100 ppm of protease, and NC + 200 ppm of protease. Each treatment contained six replicates of 43 animals each. The inclusion of proteases in the diet had effects (P < 0.05) on body weight, feed intake, weight gain, and feed conversion in the 12 to 21 day period; body weight, weight gain, and feed intake in the 29 to 42 day period; nutrient digestibility (energy metabolizability coefficient and crude protein at 28 days); and intestinal parameters (crypt and muscle width of jejunum and ileum at 28 days and villus length, crypt length, and jejunum thickness muscle layer at 42 days). These results indicate that the inclusion of protease in broiler feed can improve production parameters when the amount of crude protein in the diet is reduced.


Asunto(s)
Dieta con Restricción de Proteínas , Péptido Hidrolasas , Animales , Péptido Hidrolasas/metabolismo , Dieta con Restricción de Proteínas/veterinaria , Pollos/fisiología , Dieta/veterinaria , Nutrientes/fisiología , Carne , Peso Corporal , Aumento de Peso , Alimentación Animal/análisis , Suplementos Dietéticos , Fenómenos Fisiológicos Nutricionales de los Animales
2.
Pediatr Surg Int ; 38(12): 1723-1728, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36129533

RESUMEN

PURPOSE: Limited research exists about the knowledge that adult patients have about their congenital colorectal diagnosis. METHODS: This was an IRB approved, prospective study of patients in the Adult Colorectal Research Registry who completed surveys between October 2019 and March 2022. Surveys were administered through REDCap after patients consented to being contacted for research purposes. Patients provided demographic data, which was linked to surgical records, and the diagnoses provided by patients were compared with diagnoses recorded by the original surgeons. RESULTS: One hundred and thirty-one questionnaires were collected, 115 patients had anorectal malformations (ARM) and 16 had Hirschsprung disease (HD). Seven patients who had ARM were unaware that they had an ARM or HD. The type of ARM recorded by the surgeon was unavailable for comparison with the patient's reported diagnosis in four cases. Of the 111 remaining patients with ARM, only 32 of them (29%) knew what their own type of anomaly was. Female patients recalled their diagnosis more often than male patients (42.4% vs 13.5%). All 16 participants with HD correctly identified their diagnosis severity as HD with or without total colonic aganglionosis. CONCLUSION: The results of this study demonstrate patient's limited understanding of their type of ARM and highlight the urgent need to enhance communication and education strategies, such as issuing patients with medical diagnosis identification cards. It is critical for clinicians to better communicate with patients to ensure that they and their relatives truly understand their precise diagnosis. Adequately informed patients can better advocate for themselves, adhere to treatments and precautionary recommendations and navigate the complexities of transitional care. Consequently they can more effectively manage their lifelong complications.


Asunto(s)
Malformaciones Anorrectales , Neoplasias Colorrectales , Enfermedad de Hirschsprung , Adulto , Humanos , Masculino , Femenino , Estudios Prospectivos , Malformaciones Anorrectales/diagnóstico , Malformaciones Anorrectales/cirugía , Malformaciones Anorrectales/complicaciones , Enfermedad de Hirschsprung/diagnóstico , Enfermedad de Hirschsprung/cirugía , Enfermedad de Hirschsprung/complicaciones , Encuestas y Cuestionarios , Neoplasias Colorrectales/complicaciones
3.
Med Oral Patol Oral Cir Bucal ; 27(6): e569-e577, 2022 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-36173721

RESUMEN

BACKGROUND: Rhabdomyosarcoma (RMS) is a soft tissue malignant tumor of mesenchymal cell origin, which usually shows variable differentiation of muscle cells. It is the most common solid sarcoma in children. The most usual site of occurrence are the head and neck regions. RMS presents a variety of histologic features, and so differential diagnosis with other small round cell tumors is needed. Hence, it has been very useful to the field to undertake additional immunohistochemical studies to determine the diagnosis and, on occasions, to assign subtype tumors. MATERIAL AND METHODS: A systematic review of three databases (Medline, Biological Science Collection and Health & Medical Collection) was carried out with the purpose of analyzing rhabdomyosarcoma cases reported in the literature, specifically with localization in the head and neck regions in children. This strategy allowed us to identify the main anatomical site of appearance, the subtype of RMS, average age, histologic characteristics and immunohistochemistry markers used in a usual and any additional way. RESULTS: According to the selection criteria in this systematic review, twelve articles, and fourteen cases were identified that highlight that the histological diagnosis usually presents cellular heterogeneity. Therefore, immunohistochemistry is needed to confirm the diagnosis. CONCLUSIONS: Histologic characterization is not always sufficient for a conclusive diagnosis of RMS. Therefore, immunohistochemistry is helpful to determine the subtype and consequently, sometimes the behavior, treatment and prognosis. Additional markers may vary according to the institution and the need of particular cases.


Asunto(s)
Rabdomiosarcoma , Niño , Humanos , Rabdomiosarcoma/diagnóstico , Inmunohistoquímica , Pronóstico , Diagnóstico Diferencial
4.
Phys Chem Chem Phys ; 23(40): 23158-23172, 2021 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-34617942

RESUMEN

Herein, we compared the ability of linear and cyclic peptides generated in silico to target different protein sites: internal pockets and solvent-exposed sites. We selected human lysozyme (HuL) as a model target protein combined with the computational evolution of linear and cyclic peptides. The sequence evolution of these peptides was based on the PARCE algorithm. The generated peptides were screened based on their aqueous solubility and HuL binding affinity. The latter was evaluated by means of scoring functions and atomistic molecular dynamics (MD) trajectories in water, which allowed prediction of the structural features of the protein-peptide complexes. The computational results demonstrated that cyclic peptides constitute the optimal choice for solvent exposed sites, while both linear and cyclic peptides are capable of targeting the HuL pocket effectively. The most promising binders found in silico were investigated experimentally by surface plasmon resonance (SPR), nuclear magnetic resonance (NMR), and electrospray ionization mass spectrometry (ESI-MS) techniques. All tested peptides displayed dissociation constants in the micromolar range, as assessed by SPR; however, both NMR and ESI-MS suggested multiple binding modes, at least for the pocket binding peptides. A detailed NMR analysis confirmed that both linear and cyclic pocket peptides correctly target the binding site they were designed for.


Asunto(s)
Ligandos , Simulación de Dinámica Molecular , Muramidasa/química , Péptidos/química , Algoritmos , Secuencia de Aminoácidos , Sitios de Unión , Muramidasa/metabolismo , Resonancia Magnética Nuclear Biomolecular , Péptidos/metabolismo , Péptidos Cíclicos/química , Péptidos Cíclicos/metabolismo , Unión Proteica , Espectrometría de Masa por Ionización de Electrospray , Resonancia por Plasmón de Superficie
5.
Rev Neurol (Paris) ; 177(5): 451-458, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-32800350

RESUMEN

This review will discuss conventional and advanced magnetic resonance (MRI) imaging techniques used to study the spine and spinal cord according to the anatomical structures and clinical indications. Clinical challenges that neuroradiologists may face are also discussed, such as the "when" and "where" concerning the use of each technique, and in which pathology or clinical scenario each technique is useful. Finally, some "tips and tricks" to overcome the challenges are provided with clinical examples.


Asunto(s)
Médula Espinal , Columna Vertebral , Humanos , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Traumatismos de la Médula Espinal
6.
Biol Lett ; 16(4): 20200005, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32228400

RESUMEN

Here, we use 30 long-term, high-resolution palaeoecological records from Mexico, Central and South America to address two hypotheses regarding possible drivers of resilience in tropical forests as measured in terms of recovery rates from previous disturbances. First, we hypothesize that faster recovery rates are associated with regions of higher biodiversity, as suggested by the insurance hypothesis. And second, that resilience is due to intrinsic abiotic factors that are location specific, thus regions presently displaying resilience in terms of persistence to current climatic disturbances should also show higher recovery rates in the past. To test these hypotheses, we applied a threshold approach to identify past disturbances to forests within each sequence. We then compared the recovery rates to these events with pollen richness before the event. We also compared recovery rates of each site with a measure of present resilience in the region as demonstrated by measuring global vegetation persistence to climatic perturbations using satellite imagery. Preliminary results indeed show a positive relationship between pre-disturbance taxonomic richness and faster recovery rates. However, there is less evidence to support the concept that resilience is intrinsic to a region; patterns of resilience apparent in ecosystems presently are not necessarily conservative through time.


Asunto(s)
Ecosistema , Bosques , Biodiversidad , México , América del Sur , Árboles
7.
Rev Med Chil ; 148(10): 1398-1405, 2020 Oct.
Artículo en Español | MEDLINE | ID: mdl-33844709

RESUMEN

BACKGROUND: The prevalence of cholelithiasis and gallbladder cancer may be different across ethnic groups. AIM: To study the prevalence of cholelithiasis and gallbladder cancer among Aymara individuals. MATERIAL AND METHODS: An abdominal ultrasound was carried out in a sample of 182 Aymara women aged 46 ± 16 years and 76 Aymara men aged 55 ± 16 years. In addition, the histopathological reports of both patients with a history of previous cholecystectomy and those operated after the study were reviewed. RESULTS: Ultrasound was normal in 150 participants (58%), 76 had cholelithiasis (30%) and 32 (12%) had a history of cholecystectomy. Pathological reports of the excised gallbladder were available for 106 cases and showed a chronic cholecystitis in 98% of cases. Gallbladder cancer was not reported. CONCLUSIONS: There is a 42% prevalence of cholelithiasis and no gallbladder cancer in this sample of Aymara population.


Asunto(s)
Colecistitis , Colelitiasis , Neoplasias de la Vesícula Biliar , Adulto , Anciano , Colecistectomía , Colecistitis/cirugía , Colelitiasis/diagnóstico por imagen , Colelitiasis/epidemiología , Colelitiasis/cirugía , Femenino , Neoplasias de la Vesícula Biliar/diagnóstico por imagen , Neoplasias de la Vesícula Biliar/epidemiología , Neoplasias de la Vesícula Biliar/cirugía , Humanos , Masculino , Persona de Mediana Edad , Prevalencia
8.
Bull Environ Contam Toxicol ; 102(2): 186-190, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30600389

RESUMEN

Litopenaeus vannamei juveniles were exposed to sublethal levels (2.33-18.03 µg/L) of inorganic mercury. Time of exposure (0, 24 and 168 h) was a source of DNA damage. Mean comet tail length not changed significantly with mercury concentrations and exposure time, and this parameter cannot be used to assess DNA damage in this shrimp. Total hemocyte count showed a trend to decrease according to the increase of mercury concentrations, although no significant difference between treatments with mercury was observed. The phenoloxidase (PO) activity was not influenced by the time of exposure. At the end of the experiment, the PO in organisms exposed to 18.03 µg/L was different from the control. The time of exposure has a more important influence in superoxide dismutase than the concentration of mercury. According to these results, a suitable criterion of water quality for long-term exposure of L. vannamei should be lower than 2 µg/L of mercury.


Asunto(s)
Daño del ADN , Mercurio/toxicidad , Penaeidae/inmunología , Animales , Relación Dosis-Respuesta a Droga , Hemocitos/efectos de los fármacos , Inmunidad Innata , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/metabolismo
11.
Hematol Oncol ; 35(4): 894-899, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26947932

RESUMEN

Ring 21 is an unstable structural abnormality of chromosome 21 that can lead to RUNX1 gene amplification. We present a unique case with a carrier patient of a constitutional ring chromosome 21 (partial monosomy and trisomy 21) with dysmorphic features and congenital malformations phenotype, who developed acute myeloid leukaemia with myelodysplasia-related changes and two ring 21 chromosomes with RUNX1 amplification. The patient's constitutional ring 21 chromosome showed alterations in tumour suppressor genes, and oncogenes, but not in RUNX1. RUNX1 gene expression at acute myeloid leukaemia diagnosis, showed no upregulation, so other genes may also be the genetic amplification targets in this patient. Copyright © 2016 John Wiley & Sons, Ltd.


Asunto(s)
Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética , Leucemia Mieloide Aguda/genética , Síndromes Mielodisplásicos/genética , Preescolar , Cromosomas Humanos Par 21/genética , Femenino , Amplificación de Genes , Humanos , Cromosomas en Anillo
12.
Analyst ; 142(10): 1682-1688, 2017 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-28181598

RESUMEN

The implausible combination of centrifugal disc microfluidics and un-covered channels provides a simple way in which Raman spectroscopy can be implemented in industrially-relevant lab-on-a disc technology. Here we demonstrate these advantages by detecting very low concentrations of melamine in liquid milk, without pre-processing, without surface enhancement of the Raman signal and with no evidence of spectral contamination from the polymeric chip itself. A limit of detection (LOD) of 203 ppm for melamine in milk was achieved from Raman spectra of milk after drying. The centrifugal disc rotation and microchannel geometry results in rapid and reliable filling of the channels and in meniscus shape control, enabling reproducible Raman detection with quantitative precision.

14.
Allergy ; 71(1): 124-8, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26405014

RESUMEN

Several studies suggest that ATP and related nucleotides play a role in the pathophysiology of asthma. However, the functionality of ectonucleotidases in this disease has been scantly investigated. We studied total ectonucleotidase activity in leukocytes from patients suffering from asthma exacerbation and explored the expression of E-NTPDase 1, 2, 3, and 8, and E-NPP1, 2, and 3, in their polymorphonuclear cells by immunofluorescence and qPCR. Leukocytes from patients with mild or moderate asthma exacerbation had similar ectonucleotidase activity than leukocytes from healthy subjects, while in patients with severe asthma exacerbation, this activity was lower. Of the ectonucleotidases studied, only E-NPP1 displayed diminished immunofluorescence and a significant decrease in its mRNA expression, both in patients with severe asthma exacerbation. This reduced E-NPP1 expression could be responsible for increased amounts of ATP or other nucleotides, capable of worsening asthma exacerbation, and warranting further investigation.


Asunto(s)
Asma/genética , Regulación de la Expresión Génica , Leucocitos/metabolismo , Hidrolasas Diéster Fosfóricas/genética , Pirofosfatasas/genética , Adenosina Trifosfato/metabolismo , Asma/diagnóstico , Asma/metabolismo , Progresión de la Enfermedad , Técnica del Anticuerpo Fluorescente , Humanos , Hidrolasas Diéster Fosfóricas/metabolismo , Pirofosfatasas/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo
15.
Pituitary ; 19(2): 127-37, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26553421

RESUMEN

PURPOSE: To evaluate the long-term safety of Pegvisomant (PEG) in the Spanish cohort of ACROSTUDY. METHODS: As of July 2013, 199 Spanish patients were included in ACROSTUDY, a global non interventional safety PEG surveillance study. Patients were observed for safety, biochemical outcome and magnetic resonance imaging evaluations. RESULTS: PEG was administered during an average period of 6.7 ± 2.1 years and a mean daily dose of 15.5 ± 7.5 mg. 48.2% of patients received PEG monotherapy. 90.9% of patients had received other medical treatment before PEG start. 195 adverse events (AEs) were reported in 88 patients (44.2%), and serious AEs were described in 31 patients (15.6%). There were no cases of liver tests >10 ULN, or permanent liver damage. Tumor size changes were locally reported in 61 cases (33.5%), with increases observed in 11 patients (6%). In acromegalic patients with diabetes mellitus a decrease in fasting serum glucose value was reported, reaching statistical significance after 1 and 4 years of treatment (-24.6 and -25.9 mg/dl, p = 0.04). After 60 months, normal or lower limit of normal (LLN) IGF-I levels were found in 67.9% of patients. 85.5% of patients showed an IGF-I normal or

Asunto(s)
Acromegalia/tratamiento farmacológico , Antagonistas de Hormonas/efectos adversos , Hormona de Crecimiento Humana/análogos & derivados , Adulto , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Femenino , Estudios de Seguimiento , Antagonistas de Hormonas/uso terapéutico , Hormona de Crecimiento Humana/efectos adversos , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Vigilancia de Productos Comercializados , Sistema de Registros , España/epidemiología , Factores de Tiempo
16.
Allergol Immunopathol (Madr) ; 44(6): 504-511, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27707587

RESUMEN

BACKGROUND: OM-85 is an immunostimulant bacterial lysate, which has been proven effective in reducing the number of lower airways infections. We investigated the efficacy of the bacterial lysate OM-85 in the primary prevention of a murine model of asthma. METHODS: In the first phase of our study the animals received doses of 0.5µg, 5µg and 50µg of OM-85 through gavage for five days (days -10 to -6 of the protocol), 10 days prior to starting the sensitisation with ovalbumin (OVA), in order to evaluate the results of dose-response protocols. A single dose (5µg) was then chosen in order to verify in detail the effect of OM-85 on the pulmonary allergic response. Total/differential cells count and cytokine levels (IL-4, IL-5, IL-13 and IFN-γ) from bronchoalveolar lavage fluid (BALF), OVA-specific IgE levels from serum, lung function and lung histopathological analysis were evaluated. RESULTS: OM-85 did not reduce pulmonary eosinophilic response, regardless of the dose used. In the phase protocol using 5µg/animal of OM-85, no difference was shown among the groups studied, including total cell and eosinophil counts in BALF, serum OVA-specific IgE, lung histopathologic findings and lung resistance. However, OM-85 decreased IL-5 and IL-13 levels in BALF. CONCLUSIONS: OM-85, administered in early life in mice in human-equivalent doses, does not inhibit the development of allergic pulmonary response in mice.


Asunto(s)
Asma/prevención & control , Extractos Celulares/administración & dosificación , Eosinófilos/efectos de los fármacos , Animales , Asma/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Eosinófilos/inmunología , Femenino , Humanos , Inmunización , Inmunoglobulina E/sangre , Ratones , Ratones Endogámicos BALB C
17.
Rev Med Chil ; 144(9): 1144-1149, 2016 Sep.
Artículo en Español | MEDLINE | ID: mdl-28060975

RESUMEN

BACKGROUND: Some rural non-Caucasian ethnic groups have genetic protective factors for the development of chronic non-communicable diseases. Studies performed in Mapuche and Aymara ethnic groups in Chile, found significantly lower prevalence rates. Aymaras are the second most common ethnic population in Chile. AIM: To determine the prevalence of cardiovascular risk factors in a native Aymara ethnic population. MATERIAL AND METHODS: We studied 276 native Aymara people with a median age of 53 years (63% women), registered in the rural clinics of Camiña and Putre. The frequency of hypertension, Type 2 Diabetes Mellitus (DM2), dyslipidemia, overweight, obesity and smoking were determined. RESULTS: The frequency of overweight and obesity was 38% and 38.4% respectively. The prevalence of hypertension and DM2 were 18.5% and 6.9% respectively. Thirty-five percent had elevated total cholesterol, 21% had high LDL cholesterol, 48% had low HDL cholesterol and 45.7% had high triglyceride levels. Two percent smoked. CONCLUSIONS: In this group of Aymara individuals, we found a markedly lower prevalence of hypertension and DM2, despite the high prevalence of obesity and dyslipidemia.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Indígenas Sudamericanos , Adulto , Anciano , Chile/epidemiología , Estudios Transversales , Diabetes Mellitus Tipo 2/epidemiología , Dislipidemias/epidemiología , Femenino , Humanos , Hipertensión/epidemiología , Indígenas Sudamericanos/etnología , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Prevalencia , Factores de Riesgo , Población Rural/estadística & datos numéricos , Adulto Joven
18.
Neurologia ; 31(9): 592-598, 2016.
Artículo en Inglés, Español | MEDLINE | ID: mdl-25542499

RESUMEN

BACKGROUND: Prognostic scales can be helpful for selecting patients for reperfusion treatment. This study aims to assess the prognostic ability of the recently published SPAN-100 index in a large cohort of stroke patients treated with intravenous thrombolysis (IV rtPA). METHODS: Using data from the prospective registery of all reperfusion treatments administered in Catalonia, we selected patients treated with IV rtPA alone between 2011 and 2012. The SPAN-100 index was calculated as the sum of age (years) and NIHSS score, and patients in the cohort were classified as SPAN-100 positive [≥ 100] or SPAN-100 negative [< 100]. We measured raw and adjusted rates of symptomatic intracerebral haemorrhage (SICH), mortality, and 3-month functional outcome (mRS 0-2) for each SPAN-100 category. Area under the ROC curve was calculated to predict the main outcome measures. RESULTS: We studied 1685 rtPA-treated patients, of whom 1405 (83%) were SPAN-100 negative. The SICH rates adjusted for sex, pre-stroke mRS, hypertension, diabetes, dyslipidaemia, ischaemic heart disease, heart failure, atrial fibrillation, prior TIA/stroke and time to thrombolysis did not differ between groups, but likelihood of functional independence (mRS 0-2) at 3 months was nearly 8 times higher in the SPAN-100 negative group than in the positive group. Furthermore, the 3-month mortality rate was 5 times higher in the SPAN-100 positive group. ROC curve analysis showed high specificities for predicting both functional independence and 3-month mortality for a cut-off point of 100. CONCLUSION: The SPAN-100 index is a simple and straightforward method that may be useful for selecting candidates for rtPA treatment in doubtful cases, and for informing patients and their relatives about likely outcomes.


Asunto(s)
Fibrinolíticos/uso terapéutico , Evaluación de Resultado en la Atención de Salud , Accidente Cerebrovascular/tratamiento farmacológico , Terapia Trombolítica , Activador de Tejido Plasminógeno/uso terapéutico , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Pronóstico , Estudios Prospectivos , Sistema de Registros , Medición de Riesgo , España , Accidente Cerebrovascular/mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA